The Week Ahead: Switch's Lockup Expires, Spotify Debuts, And More

Below is a list of notable corporate events for the week beginning April 2. Note, this list is not comprehensive and all dates are subject to change. All times are ET.

Monday

Notable Earnings

  • Switch, Inc SWCH Q4 after hours (BZ NOTE: company delayed release from March 29, citing the Good Friday holiday)

M&A

  • QUALCOMM Incorporated QCOM tender offer for NXP Semiconductors NXPI to expire at 5pm (BZ NOTE: Hart-Scott-Rodino clearance on this merger expires Tuesday, April 3; companies will seek an extension if necessary)

Tuesday
Economic

  • U.S. auto sales expected

Notable Earnings

  • The Finish Line, Inc FINL Q4 premarket

IPOs

  • Spotify Technology SPOT

Investor Events

  • Quidel Corporation QDEL analyst/investor day
  • IPO lockup expiration for Rhythm Pharmaceuticals, Inc (RYTM)
  • Ford Motor Company F sales conference call 9:15 a.m.

FDA/Biotech

  • Merck & Co, Inc MRK has PDUFA date for Keytruda sBLA for Primary Mediastinal Large B-Cell Lymphoma

Wednesday
Economic

  • U.S. Nonfarm payrolls 8:15 a.m.
  • EIA crude oil inventories 10:30 a.m.

Notable Earnings

  • CarMax Inc KMX Q4 premarket
  • Ollie’s Bargain Outlet Holdings, Inc OLLI Q4 after hours

Investor Events

  • Analyst/Investor days for: Southwest Gas Holdings, Inc SWX and Teck Resources Limited TECK
  • Pebblebrook Hotel Trust PEB non-deal roadshow with BTIG
  • IPO lockup expiration for Switch

M&A

  • Baker Mills’ $57/share mini-tender offer for Colgate-Palmolive Company CL expires at 5 p.m.

Thursday
Economic

  • U.S. initial jobless claims 8:30 a.m.
  • EIA natural gas inventories 10:30 a.m.

Notable Earnings

  • Constellation Brands, Inc STZ Q4 premarket

Investor Events

  • NetApp, Inc NTAP analyst day

Friday
Economic

  • U.S. unemployment rate 8:30 a.m.
  • Baker Hughes oil rig counts 1 p.m.

FDA/Biotech

  • Clovis Oncology, Inc CLVS has PDUFA date for Rucaparib sNDA
  • Pacira Pharmaceuticals, Inc PCRX has PDUFA date for EXPAREL sNDA (BZ NOTE: On Feb. 16, FDA AdCom voted to NOT recommend approval)
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechNewsPreviewsFDAM&AIPOsEventsEcon #sMarketsTrading IdeasGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...